Skip to main content

08-12-2019 | Haematology | Video

ASH 2019 | CARTITUDE-1: Early and deep response with B-cell maturation antigen in multiple myeloma

Deepu Madduri discusses her trial findings showing a good response to the CAR T-cell therapy JNJ-4528 in multiple myeloma patients with relapsed or refractory disease (2:53).

Funding for independent interviews at ASH 2019 was provided by F. Hoffmann-La Roche Ltd, Basel, Switzerland.

See the research in context now

with trial summaries, expert opinion and congress coverage

Image Credits